Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2006 | 12-2005 | 06-2005 | 12-2004 | 06-2004 | |
| Sales | 60 | 10 | 120 | 80 | 10 |
| Gross Profit | 60 | 10 | 120 | 80 | 10 |
| Operating Expenses | 3,470 | 940 | 2,650 | 720 | 3,400 |
| Operating Income | -3,410 | -930 | -2,530 | -640 | -3,390 |
| Other Income | 100 | 20 | 190 | 160 | 320 |
| Pre-tax Income | -3,310 | -910 | -2,340 | -480 | -3,070 |
| Income Tax | 0 | 0 | -150 | 0 | 0 |
| Net Income Continuous | -3,315 | -2,189 | -2,189 | -3,078 | -3,078 |
| Net Income | $-3,310 | $-910 | $-2,180 | $-480 | $-3,070 |
| EPS Basic Total Ops | -420.00 | -12,800.00 | -320.00 | -19,200.00 | -480.00 |
| EPS Basic Continuous Ops | -430.52 | -10,945.00 | -312.71 | -15,390.00 | -480.94 |
| EPS Diluted Total Ops | -420.00 | -12,800.00 | -320.00 | -19,200.00 | -480.00 |
| EPS Diluted Continuous Ops | -430.52 | -10,945.00 | -312.71 | -15,390.00 | -480.94 |
| EBITDA(a) | $-3,370 | $-910 | $-2,490 | $-620 | $-3,360 |